Unknown

Dataset Information

Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients.


ABSTRACT:

SUBMITTER: Liu X 

PROVIDER: S-EPMC8853335 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature